Mark Stolper

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
4 years
Director since
2023

4 years of board service in total across 2 boards, counting each seat separately. Longest: Coherus Oncology Inc., 3 years.

3 years · Since 2023
10 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 27, 2026 Starling Oncology Inc. Grant or award +31,124 — —
Jul 7, 2026 Starling Oncology Inc. Grant or award +25,833 — —
Mar 3, 2026 RadNet Inc. Grant or award +18,228 — —
Dec 10, 2025 RadNet Inc. Option exercise +35,703 $6.07 $216,717
Sep 16, 2025 RadNet Inc. Open-market sale −35,000 $73.89 $2,586,150
Jan 8, 2025 RadNet Inc. Grant or award +22,889 — —
Dec 16, 2024 RadNet Inc. Gift −275 — —
Jun 10, 2024 RadNet Inc. Open-market sale −25,000 $61.27 $1,531,750
Mar 1, 2024 RadNet Inc. Grant or award +14,072 — —
May 12, 2023 RadNet Inc. Gift −900 — —
May 4, 2023 RadNet Inc. Gift −375 — —

Questions about Mark Stolper

What boards is Mark Stolper on?

Mark Stolper sits on the boards of Coherus Oncology Inc. and Starling Oncology Inc.

How long has Mark Stolper served on boards?

Our records show at least 4 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.